A randomized trial of terlipressin plus nitroglycerin vs. balloon tamponade in the control of acute variceal hemorrhage. 1990

E Fort, and D Sautereau, and C Silvain, and P Ingrand, and B Pillegand, and M Beauchant
Unité d'Hépatologie CHU J. Bernard Poitiers, France.

A randomized trial was undertaken to determine the efficacy of nitroglycerin in addition to terlipressin infusion to improve the control of acute variceal hemorrhage compared with balloon tamponade. Forty-seven bleeding episodes in 34 cirrhotic patients were included, with terlipressin plus sublingual nitroglycerin in 23 episodes (group I) and balloon tamponade in 24 episodes (group II). At the end of the 12-hr period, hemorrhage had been equally controlled in both groups (18 of 23; 78% in group I and 19 of 24; 79% in group II). When attempted, balloon tamponade appeared more efficient in the failures of group I (4 of 4) than did terlipressin plus nitroglycerin in the failures of group II (0 of 3), although this difference was not significant. Major complications were rare (one in each group) and never required cessation of therapy. Thus terlipressin and nitroglycerin were as effective as balloon tamponade in controlling variceal hemorrhage and were associated with few minor complications.

UI MeSH Term Description Entries
D008236 Lypressin The porcine antidiuretic hormone (VASOPRESSINS). It is a cyclic nonapeptide that differs from ARG-VASOPRESSIN by one amino acid, containing a LYSINE at residue 8 instead of an ARGININE. Lys-vasopressin is used to treat DIABETES INSIPIDUS or to improve vasomotor tone and BLOOD PRESSURE. Lysine Vasopressin,Vasopressin, Lysine,8-Lysine Vasopressin,Diapid,Lys-Vasopressin,Lysyl Vasopressin,Postacton,8 Lysine Vasopressin,Lys Vasopressin,Vasopressin, 8-Lysine,Vasopressin, Lysyl
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002404 Catheterization Use or insertion of a tubular device into a duct, blood vessel, hollow organ, or body cavity for injecting or withdrawing fluids for diagnostic or therapeutic purposes. It differs from INTUBATION in that the tube here is used to restore or maintain patency in obstructions. Cannulation,Cannulations,Catheterizations
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D004630 Emergencies Situations or conditions requiring immediate intervention to avoid serious adverse results. Emergency
D004932 Esophageal and Gastric Varices Dilated blood vessels in the ESOPHAGUS or GASTRIC FUNDUS that shunt blood from the portal circulation (PORTAL SYSTEM) to the systemic venous circulation. Often they are observed in individuals with portal hypertension (HYPERTENSION, PORTAL). Esophageal Varices,Gastric Varices,Esophageal Varix,Gastric Varix,Varices, Esophageal,Varices, Gastric,Varix, Esophageal,Varix, Gastric
D005260 Female Females
D005996 Nitroglycerin A volatile vasodilator which relieves ANGINA PECTORIS by stimulating GUANYLATE CYCLASE and lowering cytosolic calcium. It is also sometimes used for TOCOLYSIS and explosives. Glyceryl Trinitrate,Anginine,Dynamite,Gilustenon,Nitrangin,Nitro-Bid,Nitro-Dur,Nitrocard,Nitroderm,Nitroderm TTS,Nitroglyn,Nitrol,Nitrolan,Nitrong,Nitrospan,Nitrostat,Perlinganit,Susadrin,Sustac,Sustak,Sustonit,Transderm Nitro,Tridil,Trinitrin,Trinitrolong,Nitro Bid,Nitro Dur,NitroBid,NitroDur,Trinitrate, Glyceryl
D006471 Gastrointestinal Hemorrhage Bleeding in any segment of the GASTROINTESTINAL TRACT from ESOPHAGUS to RECTUM. Hematochezia,Hemorrhage, Gastrointestinal,Gastrointestinal Hemorrhages,Hematochezias

Related Publications

E Fort, and D Sautereau, and C Silvain, and P Ingrand, and B Pillegand, and M Beauchant
January 1986, Hepatology (Baltimore, Md.),
E Fort, and D Sautereau, and C Silvain, and P Ingrand, and B Pillegand, and M Beauchant
June 1990, Hepatology (Baltimore, Md.),
E Fort, and D Sautereau, and C Silvain, and P Ingrand, and B Pillegand, and M Beauchant
September 1989, Hepatology (Baltimore, Md.),
E Fort, and D Sautereau, and C Silvain, and P Ingrand, and B Pillegand, and M Beauchant
May 1990, Hepatology (Baltimore, Md.),
E Fort, and D Sautereau, and C Silvain, and P Ingrand, and B Pillegand, and M Beauchant
January 2003, The Cochrane database of systematic reviews,
E Fort, and D Sautereau, and C Silvain, and P Ingrand, and B Pillegand, and M Beauchant
January 2001, The Cochrane database of systematic reviews,
E Fort, and D Sautereau, and C Silvain, and P Ingrand, and B Pillegand, and M Beauchant
November 1996, Gastroenterology,
E Fort, and D Sautereau, and C Silvain, and P Ingrand, and B Pillegand, and M Beauchant
June 1983, Texas medicine,
E Fort, and D Sautereau, and C Silvain, and P Ingrand, and B Pillegand, and M Beauchant
May 1997, Gastroenterology,
Copied contents to your clipboard!